Prolynx is a preclinical biotechnology company developing ultra-long-acting medicines for obesity, cardiometabolic, and other diseases. Its hydrogel-based microsphere platform is designed to support once-monthly and once-quarterly dosing. The company is based in Emeryville, California, and offers a collaborative environment in which team members take ownership, share knowledge, and work together on purposeful, data-driven science. The Director/Senior Director of Analytical Development will lead the development, qualification, validation, and implementation of analytical methods for preclinical and clinical-stage programs. This role establishes and executes analytical strategy across starting materials, drug substance, and drug product; supports clinical readiness and CMC regulatory submissions; and develops analytical control strategies that can mature as programs advance. The position combines strategic leadership with hands-on scientific work, including troubleshooting analytical challenges and collaborating with internal teams and external CRO/CDMO partners. The successful candidate will bring substantial pharmaceutical or biotechnology analytical development experience, including methods taken from early development through qualification or validation and GMP implementation. Experience with peptides, PEGylated molecules, complex biologics or bioconjugates, and particulates is desirable. The role may also build the company's Analytical Development capabilities as the organization grows.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree